Xywav Gets FDA Approval to Treat Rare Sleep Disorder

FRIDAY, Aug. 13, 2021 -- The drug Xywav has been approved for expanded use in adults with the rare sleep disorder idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday. It is the first drug to be approved by the FDA for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news